Recite me link

1. Do your patients over 50 years old have access to a Fracture Liaison Service (FLS)?
a. Yes
b. No commissioned FLS but pathway for bone health management of fracture patients
c. No commissioned FLS and no pathway for bone health management of fracture patients
If you answered β€˜no’ (b or c) please move on to question 15.
2. Is your FLS based in secondary care?
a. Yes
b. No
3. For 2019, what percentage of people over 50 with a fracture were offered access to a FLS?
a. (please specify πŸ™‚
4. For 2019, what percentage of people referred to FLS received an assessment within 12 weeks of fracture diagnosis?
a. (please specify πŸ™‚
5. For 2019, for those patients receiving osteoporosis drug treatment what percentage were reviewed for follow up 16 weeks from fracture?
a. (please specify πŸ™‚
6. For 2019, For those patients receiving osteoporosis drug treatment what percentage were reviewed for follow up 52 weeks from fracture?
a. (please specify πŸ™‚
7. For 2020, what percentage of people over 50 with a fracture were offered access to a FLS?
a. (please specify πŸ™‚
8. For 2020, what percentage of people referred to FLS received an assessment within 12 weeks of fracture diagnosis?
a. (please specify πŸ™‚
9. For 2020, for those patients receiving osteoporosis drug treatment what percentage were reviewed for follow up 16 weeks from fracture?
a. (please specify πŸ™‚
10. For 2020, For those patients receiving osteoporosis drug treatment what percentage were reviewed for follow up 52 weeks from fracture?
a. (please specify πŸ™‚
11. Is this a permanent service funded by a sustainable source? (e.g., commissioning, health board/trust funded)
a. Yes
b. No
c. partially (please specify:)
12. Do you take part in a national FLS audit? (e.g. FLS-DB)
a. Yes
b. No
13. Please state the name and contact details of the Clinical Lead for this service
a. (please specify)
14. Are there any areas of support you would like further information/support from the ROS? E.g., Clinical Standards, KPIs, Service Improvement / Patient Information etc.
a. (please specify πŸ™‚
For those that answered β€˜no’ to having an FLS (question 1).
15. What are the reasons you do not have an FLS, or access to an FLS for your patients?
a. (please specify πŸ™‚
16. Have you tried to establish a FLS previously?
a. Yes
b. No
c. We are in the process of developing a FLS
17. What has been the barrier/obstacles to implementing a FLS?
a. (Please specify πŸ™‚
18. If you have not tried to establish a FLS previously, why not?
a. (Please specify)
19. Do you have an osteoporosis service?
a. Yes
b. No
20. Do you have a DXA (bone density scanning) service?
a. Yes
b. No
21. Please state the name and contact details of the Clinical Leads for osteoporosis, rheumatology or musculo-skeletal, services
a. (please specify)
22. Are there any areas of support around FLS that you would like further information/support on from the ROS? E.g. patient info, Clinical Standards, KPIs, Service Improvement / Patient Information etc.
a) (Please specify)

Download response Fracture Liaison Service provision. 070721